JPMorgan Chase & Co’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63M | Buy |
428,434
+260,702
| +155% | +$3.43M | ﹤0.01% | 2607 |
|
|
2025
Q1 | $2.41M | Sell |
167,732
-22,653
| -12% | -$326K | ﹤0.01% | 3144 |
|
|
2024
Q4 | $3.19M | Buy |
190,385
+54,482
| +40% | +$913K | ﹤0.01% | 3091 |
|
|
2024
Q3 | $2.17M | Buy |
135,903
+129,335
| +1,969% | +$2.07M | ﹤0.01% | 3211 |
|
|
2024
Q2 | $59.3K | Sell |
6,568
-20,697
| -76% | -$187K | ﹤0.01% | 4838 |
|
|
2024
Q1 | $308K | Buy |
27,265
+16,635
| +156% | +$188K | ﹤0.01% | 4221 |
|
|
2023
Q4 | $84.6K | Buy |
10,630
+529
| +5% | +$4.21K | ﹤0.01% | 4840 |
|
|
2023
Q3 | $65.4K | Sell |
10,101
-49,263
| -83% | -$319K | ﹤0.01% | 4814 |
|
|
2023
Q2 | $367K | Sell |
59,364
-39,861
| -40% | -$247K | ﹤0.01% | 3927 |
|
|
2023
Q1 | $382K | Buy |
99,225
+86,478
| +678% | +$333K | ﹤0.01% | 3966 |
|
|
2022
Q4 | $39K | Buy |
12,747
+9,356
| +276% | +$28.6K | ﹤0.01% | 4808 |
|
|
2022
Q3 | $14K | Sell |
3,391
-175,023
| -98% | -$723K | ﹤0.01% | 5000 |
|
|
2022
Q2 | $869K | Buy |
178,414
+173,698
| +3,683% | +$846K | ﹤0.01% | 3564 |
|
|
2022
Q1 | $42K | Buy |
4,716
+207
| +5% | +$1.84K | ﹤0.01% | 5070 |
|
|
2021
Q4 | $51K | Buy |
4,509
+2,681
| +147% | +$30.3K | ﹤0.01% | 5062 |
|
|
2021
Q3 | $30K | Sell |
1,828
-262
| -13% | -$4.3K | ﹤0.01% | 5062 |
|
|
2021
Q2 | $47K | Buy |
+2,090
| New | +$47K | ﹤0.01% | 4956 |
|